Self-deploying boom |
| The oil monitoring and pollutant control apparatus comprises a flexible elongated body or boom ... |
|
Filter arrangement |
| It is an object of the present invention to develop a filter arrangement of the type mentioned at ... |
|
Vapor cleaning system |
| OF THE INVENTION When references are made to the accompanying drawing, the similar characters of ... |
|
Microbial degradation of obnoxious organic wastes into innocucous materials |
| We claim: 1. A biologically pure culture of Pseudomonas cepacia var., niagarous selected from the ... |
|
Process of the pulping of bleaching of vegetable material |
| A principal object of the present invention is to provide a process for producing pulp which ... |
|
Method of preparing galcatooligosaccharide |
| OF THE INVENTION According to the present invention, .beta.-galactosidase having a galactosyl ... |
|
Process for the two-stage decomposition of hemi-celluloses to xylose |
| What is claimed is: 1. In a process for the two-stage decomposition of a hemi-cellulose of a xylan-... |
|
No dig seepage pit cleaner |
| What is claimed is: 1. A seepage pit cleaner comprising a fluid conduit and a cleaning assembly, ... |
|
Organosolv delignification and saccharification process for lignocellulosic plant materials |
| We claim: 1. In a process for the production of carbohydrate hydrolysates of cellulose from a ... |
|
Tartrate catabolism gene |
| What is claimed is: 1. A method for making an incompetent unicellular microorganism host competent ... |
|
|
Claudogenic-interceptive nonapeptides
| Details |
Inventors: Foell, Theodore J.; Rees, Richard W.;
Assignee: American Home Products Corporation (New York, NY)
Primary Examiner: Phillips; Delbert R.
Assistant Examiner:
Attorney, Agent or Firm: Jackson; Richard K.
Compounds of the formula: L-p-Glu-L-His-L-Trp-L-Ser-L-Tyr-X-Y-L-Arg-L-Pro-NHC.sub.2 H.sub.5 in which X is D-Trp or D-2-(1,4-cyclohexadienyl)Gly Y is L-(N-methyl)-Leu or L-(N-methyl)-ILe or a non-toxic acid addition salt thereof, are potent ovulation inducers and claudogenic-interceptive agents useful in preventing or terminating pregnancy in mammals. |
|
DETAILED DESCRIPTION What is claimed is: 1. The compound of the formula: L-p-Glu-L-His-L-Trp-L-Ser-L-Tyr-D-Trp-L-(N-methyl)Leu-L-Arg-L-Pro-NHC. sub. 2 H. sub. 5 or a non-toxic acid addition salt thereof. 2. A method for terminating pregnancy in a female mammal which comprises administering a nonapeptide of the formula: L-p-Glu-L-His-L-Trp-Ser-L-Tyr-D-Trp-L-(N-methyl)Leu-L-Arg-L-Pro-NHC. sub. 2 H. sub. 5, or a pharmaceutically acceptable acid addition salt thereof, to said mammal, post coitally, in a daily regimen containing at least about 3 micrograms per kilogram host body weight for a time sufficient to terminate pregnancy. 3. The method of claim 2 in which said nonapeptide is administered, orally or parenterally, to said mammal following a daily regimen beginning on day one after coitus and extending through about the first eight days post implantation. 4. The method of claim 2 in which said nonapeptide is administered, orally or parenterally, following a daily regimen beginning on day one after coitus and extending through about day seven post coitus.
Description:
BACKGROUND OF THE INVENTION Many analogues of LRH have been recently produced and tested as agents for ovulation induction. Modification of the amino acid sequence of LRH has been most advantageous to date with removal of the Gly. sup. 10 group and production of the Pro-NHC. sub. 2 H. sub. 5 terminus, providing a compound reportedly three to five times as active as LRH itself. Fujino et al. , Biochem. Biophys. Res. Commun. 49 863 (1972). D-Ala. sup. 6 -LRH was subsequently shown to be more potent than LRH, by Monahan et al. , Biochemistry 12 4616 (1973). Various other D-amino acids have been inserted in 6-position of LRH and des-Gly. sup. 10 -Pro-NHC. sub. 2 H. sub. 5 -LRH to produce products with improved ovulation inducing properties. U. S. 3,913,412 and Vilchez-Martinez et al. , Biochem. Biophys. Res. Commun. 59 1226 (1974). The potency of D-Ala. sup. 6, des-Gly. sup. 10 -LRH ethylamide was reported by Coy et al. , Biochem. Biophys. Res
|
| Related patents |
|
|
LH-RH-Peptides as contraceptives
What is claimed is: 1. The method of inducing a contraceptive effect in a male of female patient which comprises parenterally administering to said patient, over a ...
|
|
|
Long lasting agonists and antagonists of LH-RH
What is claimed is: 1. A novel peptide of the formula: ##STR15## wherein for A the L- or D- N-acetyl or N-pyroGlu imino acid is a member selected from the group ...
|
|
|
Synthetic pyridyl-alanyl decapeptides having antiovulatory activity
What is claimed: 1. [N-Ac-D-2-Nal .sup.1,pCl-D-Phe.sup.2,D-3-Pal.sup.3,D-Arg.sup.6,D-Ala.sup.10 ]-LHRH. 2. Analogs of LHRH wherein position 1 is N-Ac-pCl-D-Phe, N-Ac-D-2-...
|
|
|
Combination therapy for treatment of female breast cancer
OF THE INVENTION In one preferred aspect, the present invention provides an effective method of treating breast cancer in warm-blooded female animals in need of such ...
|
|
|
Method of depositing electrostatically charged liquid coating material
What we claim is: 1. In a method of depositing liquid coating material on an article in a system in which coating material particles are formed from a thin stream of a ...
|
|
|
Mechanically viable developer materials
What is claimed is: 1. A carrier particle for electrostatographic developer mixtures, said carrier particle having an average particle diameter from between about 30 ...
|
|
|
Lithographic type diffusion transfer developing composition
It is, therefore, one object of the present invention to prepare a half-tone dot photographic original plate by the process of diffusion transfer development. Another ...
|
|
|
Polyiods benzene derivatives and X-ray contrast media containing the same
Having now described our invention what we claim as new and desire to secure by Letters Patent is: 1. A compound selected from a compound of the formula: ##STR17## in ...
|
|
|
Process for preparing 9.alpha.-OH BN alcohol
OF THE INVENTION The microorganisms which can be used to produce the compounds of the subject invention are the same as disclosed in U.S. Pat. No. 4,029,549. The ...
|
|
|
[21-leucine] human urogastrone, corresponding gene, corresponding recombinant plasmid, transformed cell and process for production thereof
The present invention is based on the confirmed findings: that a structural gene representing an hUG derivative in which the 21st amino acid residue comprises Leu which ...
|
|
|